The utility of biomarkers in acute GVHD prognostication
Blood Adv
.
2023 Sep 12;7(17):5152-5155.
doi: 10.1182/bloodadvances.2023009929.
Authors
Nikolaos Spyrou
1
,
Yu Akahoshi
1
,
Francis Ayuk
2
,
Ernst Holler
3
,
Hannah Choe
4
,
Aaron Etra
1
,
William J Hogan
5
,
Wolf Rösler
6
,
Elizabeth Hexner
7
,
Zachariah DeFilipp
8
,
Ran Reshef
9
,
Chantiya Chanswangphuwana
10
,
Muna Qayed
11
,
Sabrina Kraus
12
,
Matthias Eder
13
,
Nora Rebeka Javorniczky
14
,
Stephan A Grupp
15
,
Carrie L Kitko
16
,
Pietro Merli
17
,
Paibel Aguayo-Hiraldo
18
,
Matthias Wölfl
19
,
Janna Baez
1
,
Rahnuma Beheshti
1
,
Gilbert Eng
1
,
Sigrun Gleich
3
,
Nikolaos Katsivelos
1
,
Alina Khan
1
,
Steven Kowalyk
1
,
George Morales
1
,
Rachel Young
1
,
Ryotaro Nakamura
20
,
Yi-Bin Chen
8
,
John E Levine
1
,
James L M Ferrara
1
Affiliations
1
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
2
Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
3
Department of Hematology and Oncology, Internal Medicine III, University of Regensburg, Regensburg, Germany.
4
Division of Hematology, The James Comprehensive Cancer Center, The Ohio State University, Columbus, OH.
5
Division of Hematology, Mayo Clinic, Rochester, MN.
6
Department of Internal Medicine 5, Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany.
7
Blood and Marrow Transplantation Program, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
8
Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA.
9
Blood and Marrow Transplantation Program, Columbia University Medical Center, New York, NY.
10
Department of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
11
Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA.
12
Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
13
Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
14
Department of Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, Albert Ludwigs University, Freiburg, Germany.
15
Division of Oncology, Children's Hospital of Philadelphia and Perelman School of Medicine, Philadelphia, PA.
16
Pediatric Stem Cell Transplant Program, Vanderbilt University Medical Center, Nashville, TN.
17
Department of Hematology/Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, Rome, Italy.
18
Division of Hematology, Oncology and Blood and Marrow Transplantation, Children's Hospital of Los Angeles, Los Angeles, CA.
19
Pediatric Blood and Marrow Transplantation Program, Children's Hospital, University of Würzburg, Würzburg, Germany.
20
Hematology/Hematopoietic Cell Transplant, City of Hope National Medical Center, Duarte, CA.
PMID:
37142257
PMCID:
PMC10480526
DOI:
10.1182/bloodadvances.2023009929
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
MeSH terms
Biomarkers
Graft vs Host Disease* / diagnosis
Graft vs Host Disease* / etiology
Humans
Transplantation, Homologous
Substances
Biomarkers
Grants and funding
P01 CA039542/CA/NCI NIH HHS/United States
P30 CA196521/CA/NCI NIH HHS/United States